The FDA recently announced a collaboration with Radiological Health and Center for Drug Evaluation and Research to develop a web-based resource intended to support the current science in...
Esperion recently announced that the FDA approved Nexletol an LDL-cholesterol lowering medicine, boosting access to medicine for patients with familial hypercholesterolemia or atherosclerotic...
With the prevalence of antibiotic resistance rapidly rising, a new study published in Cell is offering a more efficient, cost-efficient strategy for antibiotic discovery using machine learning.
There...
A chronic disease management drug used to treat type 2 diabetes showed real-world efficacy, even working slightly better among patients who would have been considered ineligible to participate in phase...
The Government Accountability Office unveiled a report on Tuesday that identifies challenges and opportunities with the use of machine learning throughout the drug development lifecycle.
Machine...
As the Food and Drug Administration looks to reorganize its Office of New Drugs (OND) this year, drugmakers and industry trade groups have recommendations to inform OND’s...
An estimated $2 billion represents the total amount spent on drug development. In support of its call for expanding the use of RWE in regulatory and value-based payment decision-making for drugs and...
